Bishop John E 4
4 · Lyra Therapeutics, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Bishop John E
Chief Technology Officer
Transactions
- Award
Stock Option
2023-02-27+220,000→ 220,000 totalExercise: $2.31Exp: 2033-02-26→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the underlying shares on February 27, 2024 and in 36 substantially equal monthly installments thereafter.